The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events

被引:0
|
作者
Gennaro Galasso
Gaetano Santulli
Federico Piscione
Roberta De Rosa
Valentina Trimarco
Raffaele Piccolo
Salvatore Cassese
Guido Iaccarino
Bruno Trimarco
Massimo Chiariello
机构
[1] Federico II University School of Medicine,Department of Clinical Medicine, Cardiovascular and Immunologic Sciences
关键词
Percutaneous Coronary Intervention; Acute Myocardial Infarction; Transient Ischemic Attack; Peripheral Artery Disease; Major Adverse Cardiac Event;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Increased risk of cardiovascular events associated with the GPIIIA PlA2 polymorphism.
    De Rosa, R.
    Galasso, G.
    Piscione, F.
    Santulli, G.
    Iaccarino, G.
    Piccolo, R.
    Luciano, R.
    Chiariello, M.
    CARDIOVASCULAR RESEARCH, 2010, 87 : S74 - S75
  • [2] The GPIIIA PIA2 polymorphism is associated with an increased risk of cardiovascular adverse events
    Galasso, Gennaro
    Santulli, Gaetano
    Piscione, Federico
    De Rosa, Roberta
    Trimarco, Valentina
    Piccolo, Raffaele
    Cassese, Salvatore
    Iaccarino, Guido
    Trimarco, Bruno
    Chiariello, Massimo
    BMC CARDIOVASCULAR DISORDERS, 2010, 10
  • [3] Increased platelet aggregability associated with platelet GPIIIa PLA2 polymorphism
    Feng, DL
    Lindpaintner, K
    Larson, MG
    ODonnell, CJ
    Lipinska, I
    Schmitz, C
    Sutherland, P
    Muller, JE
    Levy, D
    Tofler, GH
    CIRCULATION, 1997, 96 (08) : 2301 - 2301
  • [4] The GPIIIA PIA2 Polymorphism is Associated with an Increased Risk of Cardiovascular Adverse Event
    Galasso, Gennaro
    Santulli, Gaetano
    Piscione, Federico
    Iaccarino, Giddo
    De Rosa, Roberta
    Piccolo, Raffaele
    Trimarco, Bruno
    Chiariello, Massimo
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 80D - 80D
  • [5] Increased platelet sensitivity related to GPIIIa polymorphism (HPA-1b/PLA2)
    Zotz, RB
    Deitenbeck, R
    Rehfeld, ISB
    MaruhnDebowski, B
    Giers, G
    Bauer, H
    Winkelmann, BR
    Scharf, RE
    CIRCULATION, 1997, 96 (08) : 3713 - 3713
  • [6] EVIDENCE THAT A GPIIIA POLYMORPHISM IS RESPONSIBLE FOR THE PLA1 AND PLA2 ALLOANTIGENS BY HETEROLOGOUS EXPRESSION OF THE PLATELET GPIIIA
    KOLODZIEJ, M
    GOLDBERGER, A
    PONCZ, M
    NEWMAN, P
    BENNETT, JS
    CLINICAL RESEARCH, 1990, 38 (02): : A425 - A425
  • [7] PlA1/PlA2 polymorphism of platelet GPIIIa receptor and microangiopathy in type 1 diabetes
    Pucci, L
    Nannipieri, M
    Bandinelli, S
    Pilo, M
    Rizzo, L
    Zerbini, G
    Mangili, R
    Penno, G
    DIABETES, 1998, 47 : A130 - A130
  • [8] Platelet PlA2 polymorphism and thromboembolic events: From inherited risk to pharmacogenetics
    Goldschmidt-Clermont, PJ
    Roos, CM
    Cooke, GE
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1999, 8 (02) : 89 - 103
  • [9] Platelet PlA2 Polymorphism and Thromboembolic Events: From Inherited Risk to Pharmacogenetics
    Pascal J. Goldschmidt-Clermont
    Christine M. Roos
    Glen E. Cooke
    Journal of Thrombosis and Thrombolysis, 1999, 8 : 89 - 103
  • [10] PlA1/PlA2 polymorphism of platelet GPIIIa receptor and microangiopathy in type 1 diabetic patients
    Pucci, L
    Nannipieri, M
    Bandinelli, S
    Pilo, M
    Mangili, R
    Navalesi, R
    Penno, G
    DIABETOLOGIA, 1998, 41 : A296 - A296